Use of Diabetes Monitoring Tests in Primary Care Suboptimal
FRIDAY, Jan. 11, 2019 -- Many primary care patients are not given tests recommended for monitoring diabetes, according to a study published in the December issue of Family Medicine and Community Health.
Mingliang Dai, Ph.D., from the American Board of Family Medicine in Lexington, Kentucky, and colleagues examined adherence to ordering hemoglobin A1c (HbA1c) and lipid profile tests as recommended by the American Diabetes Association using the 2013 National Ambulatory Medical Care Survey. Data were included for 2,379 primary care visits for patients with diabetes.
The researchers found that less than 60.0 percent of the patients were given a test recommended for monitoring diabetes (58.0 percent for HbA1c and 57.0 percent for lipid profile) in the preceding 12 months. With continuity of care with primary care physicians (PCPs), the odds of adhering to diabetes monitoring guidelines increased by 36.0 (P = 0.06) and 76.0 percent (P = 0.0006) for the HbA1c and lipid profile tests, respectively.
"Forty percent of primary care visits of patients with diabetes were missed opportunities where PCPs were not providing guideline-concordant monitoring tests, creating a substantial gap in the quality of care for diabetes in U.S. primary care settings," the authors write. "Our findings suggest that enhancing patient-provider continuity of care may be effective in promoting guideline adherence."
© 2020 HealthDay. All rights reserved.
Posted: January 2019
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
- Monthly Update Archive
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.